FGL1 and cancer: It was reported that elevated fibrinogen-like protein 1 (FGL1), a major LAG-3 functional ligand independent from MHC-II, is associated with a poor prognosis and resistance to anti-PD-1/B7-H1 therapy in cancer patients.